AI in Pathology Market Size, Share, Trends, Growth Outlook

AI in Pathology Market is estimated to increase at a Compounded Annual Growth Rate of 16.1% CAGR over the forecast period from 2024 to 2030

The AI in Pathology Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Component (Software, Scanners), By Network (Generative adversarial networks (GANs), Convolutional neural networks (CNNs), Recurrent neural networks (RNNs), Others), By Application (Drug Discovery, Disease Diagnosis & Prognosis, Clinical Workflow, Training & Education), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, Academic & Research Institutes).

An Introduction to AI in Pathology Market in 2024

In the realm of pathology, artificial intelligence (AI) is poised to revolutionize diagnostic practices and transform the field by leveraging advanced machine learning algorithms to analyze histopathological images with unprecedented accuracy and efficiency. In 2024, AI-driven pathology solutions encompass a diverse array of applications, including image analysis, pattern recognition, and predictive modeling, enabling pathologists to interpret tissue specimens, detect abnormalities, and classify diseases with greater speed and precision. These AI systems leverage deep learning algorithms trained on vast repositories of annotated pathology images to identify subtle histological features, stratify risk, and guide treatment decisions, augmenting pathologists' expertise and enhancing diagnostic reproducibility. By automating routine tasks, reducing diagnostic variability, and enabling high-throughput image analysis, AI in pathology promises to revolutionize diagnostic workflows, accelerate turnaround times, and improve patient outcomes in the era of precision medicine.

Market Trend: Adoption of Digital Pathology Platforms

One prominent trend in the AI in pathology market is the increasing adoption of digital pathology platforms. Digital pathology solutions enable the digitization of histopathology slides, allowing pathologists to view, analyze, and interpret tissue samples digitally using computerized systems. This trend is driven by the need for more efficient and scalable pathology workflows, improved collaboration among pathologists, and the integration of AI-driven image analysis algorithms for enhanced diagnostic accuracy and efficiency. Digital pathology platforms facilitate remote consultation, image sharing, and telepathology services, enabling pathologists to access expertise and resources beyond geographical boundaries and enhancing the quality and timeliness of diagnostic services.

Market Driver: Demand for Enhanced Diagnostic Accuracy and Workflow Efficiency

A significant driver in the AI in pathology market is the growing demand for enhanced diagnostic accuracy and workflow efficiency. Pathologists face increasing workloads, complexity of cases, and diagnostic challenges, leading to a need for tools and technologies that can assist in interpreting pathology images and improving diagnostic confidence. AI-driven image analysis algorithms offer the potential to augment pathologists' capabilities by automating routine tasks, identifying subtle patterns and features, and providing quantitative measurements to support diagnostic decision-making. This driver is fueled by the imperative to improve patient outcomes, reduce diagnostic errors, and optimize pathology workflow efficiency in healthcare settings.

Market Opportunity: Development of AI-Powered Diagnostic Assistants

An emerging opportunity in the AI in pathology market is the development of AI-powered diagnostic assistants for pathologists. As AI algorithms continue to advance in their ability to analyze pathology images, there is an opportunity to create intelligent diagnostic support tools that can assist pathologists in interpreting slides, identifying abnormalities, and making accurate diagnoses. These AI-powered diagnostic assistants can help pathologists prioritize cases, detect rare or challenging findings, and provide decision-support recommendations based on evidence-based guidelines and expert knowledge. By integrating AI-powered diagnostic assistants into pathology workflow systems, laboratories can improve diagnostic accuracy, reduce turnaround times, and optimize resource utilization, ultimately enhancing the quality and efficiency of pathology services. This presents a significant opportunity for AI technology developers, pathology laboratories, and healthcare organizations to collaborate in developing innovative solutions that leverage AI to augment pathologists' expertise and improve diagnostic outcomes in pathology practice.

AI in Pathology Market Share Analysis: Software is the fastest growing segment over the forecast period to 2030

In the AI in Pathology Market, the Software segment is experiencing the fastest growth. This growth is driven by several key factors. Firstly, software serves as the foundation for developing and deploying AI algorithms in pathology applications. With the increasing complexity of pathology tasks such as disease diagnosis, prognosis, and drug discovery, there is a growing demand for advanced software solutions that can efficiently analyze large volumes of pathological images and data. Additionally, software plays a crucial role in integrating AI algorithms with existing pathology workflows and systems, enabling seamless integration into clinical practice. Moreover, advancements in machine learning and deep learning techniques are driving the development of more sophisticated and accurate AI algorithms for pathology applications, further fueling the demand for software solutions. Furthermore, the rising adoption of digital pathology solutions and whole-slide imaging technologies in pathology laboratories and research institutes is creating opportunities for software vendors to develop AI-driven pathology solutions that can improve diagnostic accuracy, streamline workflows, and enhance productivity. Overall, the combination of technological advancements, increasing demand for AI-driven pathology solutions, and the growing adoption of digital pathology technologies is driving the rapid growth of the software segment in the AI in Pathology Market.

AI in Pathology Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAiforia Technologies Oyj, Aiosyn Inc, Akoya Biosciences Inc, Deep Bio Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Ibex Medical Analytics Ltd, Indica Labs Inc, Koninklijke Philips N.V., Lumea Inc, Mindpeak GmbH, OptraSCAN Inc, Paige.AI Inc, PathAI Inc, Techcyte Inc, Tempus Labs Inc, Tribun Health Inc, Visiopharm A/S

AI in Pathology Market Segmentation

By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

AI in Pathology Market Companies

Aiforia Technologies Oyj
Aiosyn Inc
Akoya Biosciences Inc
Deep Bio Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Ibex Medical Analytics Ltd
Indica Labs Inc
Koninklijke Philips N.V.
Lumea Inc
Mindpeak GmbH
OptraSCAN Inc
Paige.AI Inc
PathAI Inc
Techcyte Inc
Tempus Labs Inc
Tribun Health Inc
Visiopharm A/S

Reasons to Buy the AI in Pathology Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the AI in Pathology Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the AI in Pathology Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 AI in Pathology Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global AI in Pathology Market Size Outlook, $ Million, 2021 to 2030
3.2 AI in Pathology Market Outlook by Type, $ Million, 2021 to 2030
3.3 AI in Pathology Market Outlook by Product, $ Million, 2021 to 2030
3.4 AI in Pathology Market Outlook by Application, $ Million, 2021 to 2030
3.5 AI in Pathology Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of AI in Pathology Industry
4.2 Key Market Trends in AI in Pathology Industry
4.3 Potential Opportunities in AI in Pathology Industry
4.4 Key Challenges in AI in Pathology Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global AI in Pathology Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global AI in Pathology Market Outlook by Segments
7.1 AI in Pathology Market Outlook by Segments, $ Million, 2021- 2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes

8 North America AI in Pathology Market Analysis and Outlook To 2030
8.1 Introduction to North America AI in Pathology Markets in 2024
8.2 North America AI in Pathology Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America AI in Pathology Market size Outlook by Segments, 2021-2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes

9 Europe AI in Pathology Market Analysis and Outlook To 2030
9.1 Introduction to Europe AI in Pathology Markets in 2024
9.2 Europe AI in Pathology Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe AI in Pathology Market Size Outlook by Segments, 2021-2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes

10 Asia Pacific AI in Pathology Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific AI in Pathology Markets in 2024
10.2 Asia Pacific AI in Pathology Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific AI in Pathology Market size Outlook by Segments, 2021-2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes

11 South America AI in Pathology Market Analysis and Outlook To 2030
11.1 Introduction to South America AI in Pathology Markets in 2024
11.2 South America AI in Pathology Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America AI in Pathology Market size Outlook by Segments, 2021-2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
12 Middle East and Africa AI in Pathology Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa AI in Pathology Markets in 2024
12.2 Middle East and Africa AI in Pathology Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa AI in Pathology Market size Outlook by Segments, 2021-2030
By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Aiforia Technologies Oyj
Aiosyn Inc
Akoya Biosciences Inc
Deep Bio Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Ibex Medical Analytics Ltd
Indica Labs Inc
Koninklijke Philips N.V.
Lumea Inc
Mindpeak GmbH
OptraSCAN Inc
Paige.AI Inc
PathAI Inc
Techcyte Inc
Tempus Labs Inc
Tribun Health Inc
Visiopharm A/S

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Component
Software
Scanners
By Network
Generative adversarial networks (GANs)
Convolutional neural networks (CNNs)
Recurrent neural networks (RNNs)
Others
By Application
Drug Discovery
Disease Diagnosis & Prognosis
Clinical Workflow
Training & Education
By End-User
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)